Thursday, February 12, 2015

Oncogene - Table of Contents alert Volume 34 Issue 7

If you are unable to see the message below, click here to view.
Oncogene

Advertisement
   New! Transcription factor ChIP-seq with complete ease
 
   iDeal ChIP-seq Kit for Transcription Factors
 
   •    Start-to-finish ChIP including control antibodies and primers. 
   •    Validated by the epigenetics community, including BLUEPRINT 
   •    Tackles the toughest transcription factor ChIPs 

Learn more

TABLE OF CONTENTS

Volume 34, Issue 7 (February 2015)

In this issue
Review
Original Articles

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics.

Explore the benefits of submitting your next research article: http://bit.ly/1vUuaXe

Review

Top

Application of molecular technologies for phosphoproteomic analysis of clinical samples

M Pierobon, J Wulfkuhle, L Liotta and E Petricoin

Oncogene 2015 34: 805-814; advance online publication, March 10, 2014; 10.1038/onc.2014.16

Abstract | Full Text

Original Articles

Top

IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor–stroma interaction

C Rupp, M Scherzer, A Rudisch, C Unger, C Haslinger, N Schweifer, M Artaker, H Nivarthi, R Moriggl, M Hengstschläger, D Kerjaschki, W Sommergruber, H Dolznig and P Garin-Chesa

Oncogene 2015 34: 815-825; advance online publication, March 17, 2014; 10.1038/onc.2014.18

Abstract | Full Text

MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy

T-I Hsu, S-C Lin, P-S Lu, W-C Chang, C-Y Hung, Y-M Yeh, W-C Su, P-C Liao and J-J Hung

Oncogene 2015 34: 826-837; advance online publication, March 17, 2014; 10.1038/onc.2014.22

Abstract | Full Text

Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signaling

Y Hasegawa, M Takahashi, S Ariki, D Asakawa, M Tajiri, Y Wada, Y Yamaguchi, C Nishitani, R Takamiya, A Saito, Y Uehara, J Hashimoto, Y Kurimura, H Takahashi and Y Kuroki

Oncogene 2015 34: 838-845; advance online publication, March 10, 2014; 10.1038/onc.2014.20

Abstract | Full Text

Mdmx promotes genomic instability independent of p53 and Mdm2

A M Carrillo, A Bouska, M P Arrate and C M Eischen

Oncogene 2015 34: 846-856; advance online publication, March 10, 2014; 10.1038/onc.2014.27

Abstract | Full Text

Anti-apoptotic BCL-2 proteins govern cellular outcome following B-RAFV600E inhibition and can be targeted to reduce resistance

M N Serasinghe, D J Missert, J J Asciolla, S Podgrabinska, S Y Wieder, S Izadmehr, G Belbin, M Skobe and J E Chipuk

Oncogene 2015 34: 857-867; advance online publication, March 10, 2014; 10.1038/onc.2014.21

Abstract | Full Text

DEK promotes HPV-positive and -negative head and neck cancer cell proliferation

A K Adams, G E Hallenbeck, K A Casper, Y J Patil, K M Wilson, R J Kimple, P F Lambert, D P Witte, W Xiao, M L Gillison, K A Wikenheiser-Brokamp, T M Wise-Draper and S I Wells

Oncogene 2015 34: 868-877; advance online publication, March 10, 2014; 10.1038/onc.2014.15

Abstract | Full Text

SAA1 polymorphisms are associated with variation in antiangiogenic and tumor-suppressive activities in nasopharyngeal carcinoma

H L Lung, O Y Man, M C Yeung, J M Y Ko, A K L Cheung, E W L Law, Z Yu, W H Shuen, E Tung, S H K Chan, D K Bangarusamy, Y Cheng, X Yang, R Kan, Y Phoon, K C Chan, D Chua, D L Kwong, A W M Lee, M F Ji and M L Lung

Oncogene 2015 34: 878-889; advance online publication, March 10, 2014; 10.1038/onc.2014.12

Abstract | Full Text

Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway

M Miyake, S Goodison, A Lawton, E Gomes-Giacoia and C J Rosser

Oncogene 2015 34: 890-901; advance online publication, February 24, 2014; 10.1038/onc.2014.2

Abstract | Full Text

The FEN1 E359K germline mutation disrupts the FEN1–WRN interaction and FEN1 GEN activity, causing aneuploidy-associated cancers

L Chung, D Onyango, Z Guo, P Jia, H Dai, S Liu, M Zhou, W Lin, I Pang, H Li, Y-C Yuan, Q Huang, L Zheng, J Lopes, A Nicolas, W Chai, D Raz, K L Reckamp and B Shen

Oncogene 2015 34: 902-911; advance online publication, March 10, 2014; 10.1038/onc.2014.19

Abstract | Full Text

Altered p53 regulation of miR-148b and p55PIK contributes to tumor progression in colorectal cancer

G Wang, X Cao, S Lai, X Luo, Y Feng, J Wu, Q Ning, X Xia, J Wang, J Gong and J Hu

Oncogene 2015 34: 912-921; advance online publication, March 17, 2014; 10.1038/onc.2014.30

Abstract | Full Text

Renal tumours in a Tsc2+/ mouse model do not show feedback inhibition of Akt and are effectively prevented by rapamycin

J Yang, M Kalogerou, P A Samsel, Y Zhang, D F R Griffiths, J Gallacher, J R Sampson and M H Shen

Oncogene 2015 34: 922-931; advance online publication, March 17, 2014; 10.1038/onc.2014.17

Abstract | Full Text

MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2

M P Gillam, D Nimbalkar, L Sun, K Christov, D Ray, P Kaldis, X Liu and H Kiyokawa

Oncogene 2015 34: 932-938; advance online publication, February 17, 2014; 10.1038/onc.2014.3

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: